<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30583851</article-id>
<article-id pub-id-type="pmc">6424871</article-id>
<article-id pub-id-type="publisher-id">S0006-3223(18)32009-2</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2018.11.004</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Reciprocal White Matter Changes Associated With Copy Number Variation at 15q11.2 BP1-BP2: A Diffusion Tensor Imaging Study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Ana I.</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="aff" rid="aff3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ulfarsson</surname>
<given-names>Magnus O.</given-names>
</name>
<xref ref-type="aff" rid="aff5">e</xref>
<xref ref-type="aff" rid="aff6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stefansson</surname>
<given-names>Hreinn</given-names>
</name>
<xref ref-type="aff" rid="aff5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gustafsson</surname>
<given-names>Omar</given-names>
</name>
<xref ref-type="aff" rid="aff5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walters</surname>
<given-names>G. Bragi</given-names>
</name>
<xref ref-type="aff" rid="aff5">e</xref>
<xref ref-type="aff" rid="aff7">g</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Linden</surname>
<given-names>David E.J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="aff" rid="aff3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wilkinson</surname>
<given-names>Lawrence S.</given-names>
</name>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="aff" rid="aff3">c</xref>
<xref ref-type="aff" rid="aff4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drakesmith</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Owen</surname>
<given-names>Michael J.</given-names>
</name>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="aff" rid="aff3">c</xref>
<xref ref-type="aff" rid="aff4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hall</surname>
<given-names>Jeremy</given-names>
</name>
<email>hallj10@cardiff.ac.uk</email>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="aff" rid="aff3">c</xref>
<xref ref-type="aff" rid="aff4">d</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
<xref ref-type="fn" rid="fn1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stefansson</surname>
<given-names>Kari</given-names>
</name>
<email>kstefans@decode.is</email>
<xref ref-type="aff" rid="aff5">e</xref>
<xref ref-type="corresp" rid="cor2">∗∗</xref>
<xref ref-type="fn" rid="fn1">1</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>a</label>Cardiff University Brain Research Imaging Centre, School of Psychology, Cardiff, United Kingdom</aff>
<aff id="aff2"><label>b</label>Neuroscience and Mental Health Research Institute, Cardiff, United Kingdom</aff>
<aff id="aff3"><label>c</label>Division of Psychological Medicine and Clinical Neurosciences, Cardiff, United Kingdom</aff>
<aff id="aff4"><label>d</label>MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom</aff>
<aff id="aff5"><label>e</label>deCODE genetics/Amgen, Reykjavik, Iceland</aff>
<aff id="aff6"><label>f</label>Faculty of Electrical Engineering, Reykjavik, Iceland</aff>
<aff id="aff7"><label>g</label>Faculty of Medicine, University of Iceland, Reykjavik, Iceland</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Address correspondence to Jeremy Hall, M.D., Ph.D., Neuroscience and Mental Health Research Institute, Hadyn Ellis Building, Cathays, Cardiff, CF24 4HQ <email>hallj10@cardiff.ac.uk</email></corresp>
<corresp id="cor2"><label>∗∗</label>Kari Stefansson, M.D., Ph.D., deCODE genetics/Amgen, Sturlugata 8, IS-101 Reykjavik, Iceland. <email>kstefans@decode.is</email></corresp>
<fn id="fn1">
<label>1</label>
<p id="ntpara0010">JH and KS contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
<pub-date pub-type="ppub">
<day>01</day>
<month>4</month>
<year>2019</year>
</pub-date>
<volume>85</volume>
<issue>7</issue>
<fpage>563</fpage>
<lpage>572</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>7</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 Society of Biological Psychiatry. All rights reserved.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Society of Biological Psychiatry</copyright-holder>
<license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0010">
<sec>
<title>Background</title>
<p>The 15q11.2 BP1-BP2 cytogenetic region has been associated with learning and motor delays, autism, and schizophrenia. This region includes a gene that codes for the cytoplasmic FMR1 interacting protein 1 (<italic>CYFIP1</italic>). The CYFIP1 protein is involved in actin cytoskeletal dynamics and interacts with the fragile X mental retardation protein. Absence of fragile X mental retardation protein causes fragile X syndrome. Because abnormal white matter microstructure has been reported in both fragile X syndrome and psychiatric disorders, we looked at the impact of 15q11.2 BP1-BP2 dosage on white matter microstructure.</p>
</sec>
<sec>
<title>Methods</title>
<p>Combining a brain-wide voxel-based approach and a regional-based analysis, we analyzed diffusion tensor imaging data from healthy individuals with the deletion (<italic>n =</italic> 30), healthy individuals with the reciprocal duplication (<italic>n =</italic> 27), and IQ-matched control subjects with no large copy number variants (<italic>n =</italic> 19), recruited from a large genotyped population sample.</p>
</sec>
<sec>
<title>Results</title>
<p>We found global mirror effects (deletion &gt; control &gt; duplication) on fractional anisotropy. The deletion group showed widespread increased fractional anisotropy when compared with duplication. Regional analyses revealed a greater effect size in the posterior limb of the internal capsule and a tendency for decreased fractional anisotropy in duplication.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>These results show a reciprocal effect of 15q11.2 BP1-BP2 on white matter microstructure, suggesting that reciprocal chromosomal imbalances may lead to opposite changes in brain structure. Findings in the deletion overlap with previous white matter differences reported in fragile X syndrome patients, suggesting common pathogenic mechanisms derived from disruptions of cytoplasmic CYFIP1-fragile X mental retardation protein complexes. Our data begin to identify specific components of the 15q11.2 BP1-BP2 phenotype and neurobiological mechanisms of potential relevance to the increased risk for disorder.</p>
</sec>
</abstract>
<kwd-group id="kwrds0010">
<title>Keywords</title>
<kwd>15q11.2 BP1-BP2</kwd>
<kwd>Copy number variant</kwd>
<kwd>CYFIP1</kwd>
<kwd>Diffusion tensor imaging</kwd>
<kwd>Fragile X syndrome</kwd>
<kwd>Genetics</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p id="p0010">Copy number variants (CNVs) are rare structural variations of the genome arising from unbalanced meiotic rearrangements that can result in carriers possessing a deletion or duplication of parts of one of the chromosome pairs. An increased burden of CNVs has been observed in several neurodevelopmental and psychiatric diseases, including autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), intellectual disability, and schizophrenia <xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib2">2</xref>. How these damaging variants modify risk for psychopathology is still not well understood at the mechanistic level, but given their relatively high penetrance and cross-disorder pleiotropic effects, significant impact on brain structure and function is anticipated.</p>
<p id="p0015">Altered white matter (WM) structure has been consistently reported in psychiatric disorders. For instance, in the case of schizophrenia, neuroimaging studies have shown abnormal structural and functional connectivity at both microscopic and macroscopic levels, and such data have been central in supporting various “dysconnectivity” hypotheses of mental disease <xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref>. It follows that a key question for neurobiological research is whether CNVs that are associated with neurodevelopmental disorders, including schizophrenia, are also associated with changes in WM and brain connectivity.</p>
<p id="p0020">The 15q11.2 BP1-BP2 cytogenetic microdeletion is emerging as a recognized syndrome and has been associated with developmental, speech, language, and motor delays <xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref>, and also with increased susceptibility for epilepsy <xref ref-type="bibr" rid="bib7">(7)</xref>, ADHD <xref ref-type="bibr" rid="bib5">(5)</xref>, ASD <xref ref-type="bibr" rid="bib8">(8)</xref>, and schizophrenia <xref ref-type="bibr" rid="bib9">(9)</xref>. Moreover, recent ultra high-resolution chromosomal microarray analyses report the 15q11.2 BP1-BP2 deletion as the most frequent finding in those with only ASD or with ASD combined with intellectual disability and congenital anomalies <xref ref-type="bibr" rid="bib10">(10)</xref>. The reciprocal duplication has also been associated with increased risk for ASD <xref ref-type="bibr" rid="bib11">(11)</xref>, although its significance is still unclear <xref ref-type="bibr" rid="bib8">(8)</xref>.</p>
<p id="p0025">Not all the individuals with the BP1-BP2 microdeletion/microduplication are clinically affected, and the genes in this region have variable expressivity. Yet, healthy individuals with the deletion and without a current clinical diagnosis frequently report mild-to-moderate impairments in motor function and deficits across several cognitive domains, including an increased incidence of difficulties in mathematics and reading skills <xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref>, while healthy individuals with the duplication perform to a similar level as population control subjects <xref ref-type="bibr" rid="bib12">(12)</xref>. In a recent study by Ulfarsson <italic>et al.</italic>
<xref ref-type="bibr" rid="bib13">(13)</xref>, these cognitive deficits were shown to be accompanied by structural changes in the brain, as assessed by structural magnetic resonance imaging (MRI), in individuals with a deletion or duplication showing reciprocal structural effects, as well as by different patterns of brain activation in tests of reading and mathematics. However, the effect on WM microstructure cannot be assessed with standard MRI, and diffusion tensor imaging (DTI) studies are needed.</p>
<p id="p0030">The 15q11.2 BP1-BP2 region is adjacent to the areas affected in the Prader-Willi and Angelman syndromes, conditions resulting from deletions of the BP1-BP3 (type I) or the BP2–BP3 (type II) regions at 15q11.2, with the BP1-BP2 deletion partly overlapping the type I but not type II Prader-Willi/Angelman region. Individuals with type I deletion report more severe neurodevelopmental disturbances compared with individuals with the smaller type II deletion <xref ref-type="bibr" rid="bib14">14</xref>, <xref ref-type="bibr" rid="bib15">15</xref>. The isolated BP1-BP2 region spans ∼500 kb and encompasses four different genes: nonimprinted in Prader-Willi/Angelman syndrome 1 gene (<italic>NIPA1</italic>), nonimprinted in Prader-Willi/Angelman syndrome 2 gene (<italic>NIPA2</italic>), cytoplasmic FMR1 interacting protein 1 (<italic>CYFIP1</italic>), and tubulin gamma complex associated protein 5 gene (<italic>TUBGCP5</italic>) <xref ref-type="bibr" rid="bib16">(16)</xref>. The four genes probably play a role in brain development and function, and some work has been done to understand the extent and mechanism through which they contribute to increased risk for psychiatric disorder in the 15q11.2 BP1-BP2 region <xref ref-type="bibr" rid="bib5">(5)</xref>. For instance, the <italic>NIPA1</italic> gene is known to mediate Mg<sup>2+</sup> transport and was associated with autosomal dominant hereditary spastic paraplegia <xref ref-type="bibr" rid="bib17">(17)</xref>, which might be caused by abnormal bone morphogenic protein (BMP) signaling as a result of dysregulations in <italic>NIPA1</italic>
<xref ref-type="bibr" rid="bib18">(18)</xref>. The <italic>NIPA2</italic> gene encodes for proteins used in renal Mg<sup>2+</sup> transport and metabolism and, when mutated, can cause childhood absence epilepsy <xref ref-type="bibr" rid="bib19">(19)</xref>. <italic>TUBGCP5</italic> is highly expressed in the subthalamic nuclei, a region linked to obsessive-compulsive disorder and ADHD <xref ref-type="bibr" rid="bib20">(20)</xref>. More is known about the <italic>CYFIP1</italic> gene, which is considered a prominent candidate gene contributing to 15q11.2 BP1-BP2 brain and psychological phenotypes <xref ref-type="bibr" rid="bib21">(21)</xref>. Haploinsufficiency of <italic>Cyfip1</italic> in mouse models, recapitulating the predicted low dosage of <italic>CYFIP1</italic> in 15q11.2 BP1-BP2 microdeletion, has been shown to impact two main processes: 1) the regulation of cytoskeleton remodeling by the binding of CYFIP1 protein to RAC1, and subsequent activation of the WAVE regulatory complex neurons <xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib23">23</xref>; and 2) via direct interaction of the CYFIP1 protein with fragile X mental retardation protein (FMRP), the repression of eIF4E-mediated translation of FMRP target messenger RNAs <xref ref-type="bibr" rid="bib24">(24)</xref>. These actions of CYFIP1 protein in the brain have the potential to influence WM, the former through effects on neuronal structure and integrity and the latter via interactions with FMRP, mutations that are known to be associated with changes in WM structure <xref ref-type="bibr" rid="bib25">(25)</xref>. Loss of FMRP function, due to an expansion repeat in the <italic>FMR1</italic> gene on the long arm of the X chromosome, is a cause of fragile X syndrome (FXS), the most common monogenic form of inherited intellectual disability <xref ref-type="bibr" rid="bib26">(26)</xref>.</p>
<p id="p0035">Recently, two studies <xref ref-type="bibr" rid="bib27">27</xref>, <xref ref-type="bibr" rid="bib28">28</xref> used DTI to investigate differences in WM microstructure, comparing subjects with FXS with subjects without FXS but with similar IQ and levels of autistic symptoms (minimizing confounding effects owing to intellectual ability), and found increased fractional anisotropy (FA) as well as decreased radial diffusivity (RD) and mean diffusivity (MD) in several WM tracts in FXS subjects. Therefore, it might be anticipated, given the close molecular links between CYFIP1 and FMRP, that some degree of phenotypic overlap may be present in FXS and 15q11.2 BP1-BP2 deletion.</p>
<p id="p0040">In the present work, we employed a DTI approach to assess WM microstructural changes associated with the 15q11.2 BP1-BP2 region in an adult cohort, selected from the Icelandic population, without a known diagnosis of schizophrenia or autism, thereby potentially avoiding the confounding effects of the disorders clinical signs. Combining brain-wide voxel-based approach (FSL Tract-Based Spatial Statistics [TBSS]) with an atlas-based analysis, allowing quantification of the magnitude of regional changes, we hypothesized that we would see a similar pattern of effects as reported for FXS: increased FA in 15q11.2 BP1-BP2 deletion. We also assessed healthy adults with the reciprocal duplication to evaluate the extent of any reciprocal effects on the neural phenotype. Our data begin to identify specific components of the 15q11.2 BP1-BP2 phenotype and mechanisms of potential relevance to the increased risk for disorder.</p>
<sec id="sec1">
<title>Methods and Materials</title>
<sec id="sec1.1">
<title>Participants</title>
<p id="p0045">In total, 30 individuals with the 15q11.2 BP1-BP2 deletion, 27 with the reciprocal duplication, and 19 control subjects with no large CNVs (NoCNV) were recruited from a large genotyped sample of approximately 160,000 subjects representing half of the Icelandic population, in which none of the subjects had any other large CNVs. Subjects between 21 and 66 years of age were included in this study, and the number of female and male subjects was the same (38 men and 38 women) and balanced in each condition group. All the subjects were clinically healthy, such that subjects were excluded if they had ICD-10 or DSM-IV diagnoses for schizophrenia or schizoaffective or bipolar disorder; were diagnosed with autism, intellectual disability, or developmental delay at the State Diagnostic and Counselling Centre of Iceland (serves children and adolescents with a disability); met psychoses criteria on the Mini-International Neuropsychiatric Interview <xref ref-type="bibr" rid="bib29">(29)</xref>; were diagnosed with schizophrenia, schizoaffective or bipolar disorder, autism, intellectual disability, or developmental delay according to self-reports (or reports from parents); or were using antipsychotic medication. Approval for this study was obtained from the National Bioethics Committee of Iceland and the Icelandic Data Protection Authority.</p>
<p id="p0050">The IQ scores were assessed using an Icelandic version of the Wechsler Adult Intelligence Scale <xref ref-type="bibr" rid="bib30">30</xref>, <xref ref-type="bibr" rid="bib31">31</xref> including four subtests (vocabulary, similarities, block design, and matrix reasoning). Further details on how these individuals were genotyped and on how the cognitive assessment was performed can be found in Stefansson <italic>et al.</italic>’s <xref ref-type="bibr" rid="bib12">(12)</xref> study. There were no significant differences in the IQs between groups. Although all the individuals with the deletion were tested, only 11 of 19 from the NoCNV group and 26 of 27 from the duplication group were tested. Demographic information is described in <xref ref-type="table" rid="tbl1">Table 1</xref>, and family relationships between subjects are described in <xref ref-type="sec" rid="appsec1">Supplemental Table S2</xref>.<table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Subject Characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Age, Years</th><th>Male/Female</th><th>IQ Score<xref ref-type="table-fn" rid="tbl1fna">a</xref></th><th>Subjects (<italic>N</italic> = 76)</th></tr></thead><tbody><tr><td>Deletion</td><td align="char">42.83 ± 12.5 (21–65)</td><td align="char">14/16</td><td align="char">101.2 ± 13.8</td><td align="char">30</td></tr><tr><td>NoCNV</td><td align="char">38.95 ± 10.56 (22–59)</td><td align="char">12/7</td><td align="char">108.3 ± 16.9</td><td align="char">19</td></tr><tr><td>Duplication</td><td align="char">43.48 ± 13.51 (22–66)</td><td align="char">12/15</td><td align="char">100.8 ± 11.8</td><td align="char">27</td></tr></tbody></table><table-wrap-foot><fn id="tspara0015"><p>Values are mean ± SD (range) or <italic>n</italic>. The IQ score included four subtests (vocabulary, similarities, block design, and matrix reasoning).</p></fn><fn id="tspara0020"><p>NoCNV, no large copy number variants.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fna"><label>a</label><p id="ntpara0015">Icelandic version of the Wechsler Abbreviated Scale of Intelligence <xref ref-type="bibr" rid="bib12">(12)</xref>. The test was performed in all individuals with the deletion, in 11 of 19 individuals in the NoCNV group, and in 26 of 27 individuals with the duplication.</p></fn></table-wrap-foot></table-wrap></p>
</sec>
<sec id="sec1.2">
<title>Diffusion Tensor Imaging</title>
<p id="p0055">Water diffusion is anisotropic in healthy nerve fibers, diffusing freely along the fiber tracts but restricted in the perpendicular direction <xref ref-type="bibr" rid="bib32">(32)</xref>. DTI is sensitive to these anisotropic changes, which makes this technique particularly useful for evaluating WM microstructure <xref ref-type="bibr" rid="bib33">(33)</xref>. DTI findings are commonly reported in terms of scalars such as FA, axial diffusivity (AD), RD, and MD.</p>
</sec>
<sec id="sec1.3">
<title>Diffusion MRI Acquisition and Preprocessing</title>
<p id="p0060">MRI data were acquired on a Philips Achieva 1.5T system (Phillips Healthcare, Eindhoven, the Netherlands). A diffusion-weighted echo-planar imaging sequence with sensitivity encoding acceleration was used. Seventeen noncolinear gradient diffusion-weighted images (DWIs) at b = 800 s/mm<sup>2</sup> and one nonweighted (b = 0 s/mm<sup>2</sup>) image were acquired with the following parameters: echo time = 72 ms, repetition time = 9024 ms, 60 slices, slice thickness = 2 mm, field of view = 240 × 240 mm, acquisition matrix = 144 × 144, resulting in data acquired with a 1.67 × 1.67 × 2 mm voxel resolution.</p>
<p id="p0065">Diffusion-weighted data were preprocessed using ExploreDTI v.4.8.3 <xref ref-type="bibr" rid="bib34">(34)</xref> in MATLAB R2015a (The MathWorks, Inc., Natick, MA). First, the Brain Extraction Tool <xref ref-type="bibr" rid="bib35">(35)</xref> (<ext-link ext-link-type="uri" id="intref0010" xlink:href="http://www.fmrib.ox.ac.uk/fsl/">http://www.fmrib.ox.ac.uk/fsl/</ext-link>) was used to remove nonbrain tissue. Within the ExploreDTI pipeline, eddy currents and head motion correction was performed using an affine registration to the non–diffusion-weighted B<sub>0</sub> images, with appropriate rotation of the encoding vectors <xref ref-type="bibr" rid="bib36">(36)</xref>. Field inhomogeneities were corrected using the approach of Wu <italic>et al.</italic>
<xref ref-type="bibr" rid="bib37">(37)</xref>. Each DWI was nonlinearly warped to the T<sub>1</sub>-weighted image using the FA maps from the DWIs as a reference. Warps were computed using Elastix <xref ref-type="bibr" rid="bib38">(38)</xref>, by using normalized mutual information as the cost function and constraining deformations to the phase-encoding direction. The corrected DWIs were therefore transformed to the same (undistorted) space as the T1-weighted structural images. ExploreDTI was used to generate whole-brain maps of FA, AD, RD, and MD.</p>
</sec>
<sec id="sec1.4">
<title>TBSS Analysis of DTI</title>
<p id="p0070">The corrected FA, AD, RD, and MD maps were analyzed using the FSL’s TBSS tool. TBSS is a whole-brain analysis <xref ref-type="bibr" rid="bib39">(39)</xref> that starts with a nonlinear registration of the FA maps to a standard FA template (FMRIB58_FA, FMRIB Software Library FA adult template). Then, FA maps are thinned and averaged to create a study-specific WM skeleton template, and the registered FA maps are aligned to this template. An optimal FA threshold of 0.2 was chosen for the binary skeleton mask. Afterward, all the AD, RD, and MD maps were also registered to the FMRIB58_FA template.</p>
<p id="p0075">General linear models were created to investigate copy number effects at 15q11.2 BP1-BP2. Statistically significant differences were first assessed with a multiple regression model (duplication &gt; NoCNV &gt; deletion and deletion &gt; NoCNV &gt; duplication). Total intracranial volume, age, and sex were included as covariates of no interest. Differences in DTI measures between groups were assessed using voxelwise independent <italic>t</italic> tests (deletion vs. NoCNV, duplication vs. NoCNV, and deletion vs. duplication), in which six different contrasts were used to assess group differences (<xref ref-type="table" rid="tbl2">Table 2</xref>). The randomize function from FSL was used with the threshold-free cluster enhancement approach <xref ref-type="bibr" rid="bib40">(40)</xref>, generating cluster-size statistics based on 5000 random permutations to calculate probabilities corrected for multiple comparisons. Significant results were considered with a corrected <italic>p</italic> value &lt;.05 (<italic>p &lt;</italic> .025 for each tail of the two-tailed test). Anatomical WM regions showing significant group differences were identified with the John Hopkins University WM atlas (ICBM-DTI-81) <xref ref-type="bibr" rid="bib41">(41)</xref>.<table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Summary of Between-Group FSL Tract-Based Spatial Statistics Analyses Results</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Contrast</th><th colspan="4">Whole-Group Analysis<hr/></th></tr><tr><th>FA</th><th>AD</th><th>RD</th><th>MD</th></tr></thead><tbody><tr><td>Del &gt; NoCNV</td><td><bold>+</bold></td><td>−</td><td>−</td><td>−</td></tr><tr><td>NoCNV &gt; Del</td><td>−</td><td>−</td><td>−</td><td>−</td></tr><tr><td>NoCNV &gt; Dup</td><td>−</td><td>−</td><td>−</td><td>−</td></tr><tr><td>Dup &gt; NoCNV</td><td>−</td><td><bold>+</bold></td><td>−</td><td>−</td></tr><tr><td>Del &gt; Dup</td><td><bold>++</bold></td><td>−</td><td>−</td><td>−</td></tr><tr><td>Dup &gt; Del</td><td>−</td><td><bold>+</bold></td><td><bold>++</bold></td><td><bold>+</bold></td></tr></tbody></table><table-wrap-foot><fn id="tspara0030"><p>Significant voxelwise comparisons (<italic>p &lt;</italic> .05) are indicated by a plus sign (+) (less significant) or two plus signs (++) (more significant), and nonsignificant results (<italic>p</italic> &gt; .05) are indicated by a minus sign (−). All the <italic>p</italic> values were corrected using the threshold-free cluster enhancement algorithm in FSL Tract-Based Spatial Statistics.</p></fn><fn id="tspara0035"><p>AD, axial diffusivity; Del, deletion; Dup, duplication; FA, fractional anisotropy; MD, mean diffusivity; NoCNV, no large copy number variants; RD, radial diffusivity.</p></fn></table-wrap-foot></table-wrap></p>
</sec>
<sec id="sec1.5">
<title>Regional DTI Metrics Statistical Analyses</title>
<p id="p0080">Region values of FA, AD, RD, and MD were obtained by averaging over the intersecting voxels between the WM DTI maps with the John Hopkins University WM atlas (ICBM-DTI-81), which comprises 48 tracts <xref ref-type="bibr" rid="bib41">(41)</xref>. To investigate between-group regional differences in FA, AD, RD, and MD, linear regression analysis was performed for each DTI measure and for each WM tract, regressing out age, sex, and total intracranial volume as covariates of no interest. For these, RStudio version 1.1.463 (R Foundation for Statistical Computing, Vienna, Austria) was used to test differences between groups.</p>
<p id="p0085">To account for multiple testing in the pairwise comparisons, we used the standard false discovery rate method based on the Benjamini-Hochberg approach <xref ref-type="bibr" rid="bib42">(42)</xref>, taking into account the relation between different WM tracts and between DTI metrics. Only significant false discovery rate–adjusted <italic>p</italic> values are reported. Cohen’s <italic>d</italic> effect sizes were calculated for differences between the deletion and duplication groups <xref ref-type="bibr" rid="bib43">(43)</xref>. An interaction between sex and 15q11.2 BP1-BP2 dosage was also evaluated.</p>
</sec>
</sec>
<sec id="sec2">
<title>Results</title>
<sec id="sec2.1">
<title>Between-Group TBSS Analysis</title>
<p id="p0090">TBSS was used to assess groupwise microstructural differences in major WM pathways throughout the brain. <italic>F</italic> statistics showed extensive significant differences in the direction deletion &gt; NoCNV &gt; duplication in FA, and duplication &gt; NoCNV &gt; deletion in AD, RD, and MD. Further pairwise comparisons showed extensive and global increase in FA, and decreased AD, RD, and MD in the deletion group compared with the duplication group. These differences were seen in major WM tracts, such as the corpus callosum, superior longitudinal fasciculus, inferior longitudinal fasciculus (ILF), and internal capsule (IC). Moreover, the deletion group also showed increased FA when compared with the NoCNV group in the posterior thalamic radiation. The duplication group showed significantly increased AD when compared with the NoCNV group. The contrasts that gave rise to significant voxelwise results (<italic>p &lt;</italic> .05, corrected) are summarized in <xref ref-type="table" rid="tbl2">Table 2</xref> and TBSS results are displayed in <xref ref-type="fig" rid="fig1">Figure 1</xref>.<fig id="fig1"><label>Figure 1</label><caption><p>FSL Tract-Based Spatial Statistics whole-group voxel-based analysis. Significant results for the two-sample <italic>t</italic> test showing group differences between subjects with the deletion (Del) (<italic>n =</italic> 30), duplication (Dup) (<italic>n =</italic> 27), and no large copy number variants (NoCNV) (<italic>n =</italic> 19) for fractional anisotropy, axial diffusivity, radial diffusivity, and mean diffusivity maps. Here, only contrasts that gave rise to significant results after correction are displayed (<italic>p &lt;</italic> .05, corrected). Within the significant results, red and blue code for less significant results and yellow and green for more significant results. The deletion showed widespread increased fractional anisotropy compared with the duplication and NoCNV groups, and decreased axial diffusivity, radial diffusivity, and mean diffusivity compared with the duplication group. The duplication group showed increased axial diffusivity compared with NoCNV group.</p></caption><graphic xlink:href="gr1"></graphic></fig></p>
</sec>
<sec id="sec2.2">
<title>Between-Group Regional Analyses</title>
<p id="p0095">Results from the atlas-based segmentation were consistent with the TBSS. Plots of the data confirmed the overall pattern of increased FA in the deletion group compared with the duplication group, with the NoCNV group lying intermediate between these groups (<xref ref-type="fig" rid="fig2">Figure 2</xref>). However, the deletion group showed greater effect sizes than the duplication group when compared with the NoCNV group (<xref ref-type="sec" rid="appsec1">Supplemental Table S1</xref>). Because the pairwise comparisons were only significant between the deletion and duplication groups, we only show Cohen’s effect size plots for comparisons of the deletion group versus the duplication group. Cohen’s effect sizes for FA and AD are displayed in <xref ref-type="fig" rid="fig3">Figure 3</xref>, and for all the DTI measures in <xref ref-type="sec" rid="appsec1">Supplemental Figure S1</xref>. The largest effect size was observed for higher FA and lower RD in the posterior limb of the IC (PLIC). Across the whole brain, the effect size was medium in FA (Cohen’s <italic>d</italic> = 0.69), RD (Cohen’s <italic>d</italic> = −0.68), and MD (Cohen’s <italic>d</italic> = −0.63), and small for AD (Cohen’s <italic>d</italic> = −0.38), according to Cohen’s criteria <xref ref-type="bibr" rid="bib43">(43)</xref>. Findings are summarized in <xref ref-type="table" rid="tbl3">Table 3</xref> and extended in <xref ref-type="sec" rid="appsec1">Supplemental Table S1</xref>. As some of the subjects are related, we reanalyzed the data using only one member from each family and found the results to be consistent with initial findings/primary analyses. However, a few WM tracts became nonsignificant, possibly owing to the loss of power from reducing the cohort to 65 subjects (<xref ref-type="sec" rid="appsec1">Supplemental Figures S3 and S4</xref>).<fig id="fig2"><label>Figure 2</label><caption><p>Boxplots showing group differences for atlas-based analyses. Significant group differences in fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD) are shown after multiple comparisons correction (<italic>p &lt;</italic> .05). *<italic>p</italic> &lt; .05, **<italic>p</italic> &lt; .01, ***<italic>p</italic> &lt; .001. BCC, body of corpus callosum; LALIC, left anterior limb of the internal capsule; LC(CG), left cingulum (cingulate gyrus portion); LILF, left inferior longitudinal fasciculus; LPCR, left posterior corona radiata; LPLIC, left posterior limb of the internal capsule; LSCR, left superior corona radiata; LSLF, left superior longitudinal fasciculus; NoCNV, no large copy number variants; RACR, right anterior corona radiata; RC(CG), right cingulum (cingulate gyrus portion); RPCR, right posterior corona radiata; RPLIC, right posterior limb of the internal capsule; RPTR, right posterior thalamic radiation; RSCR, right superior corona radiata; RSLF, right superior longitudinal fasciculus; SCC, splenium of the corpus callosum.</p></caption><graphic xlink:href="gr2"></graphic></fig><fig id="fig3"><label>Figure 3</label><caption><p>Effect sizes on deletion versus duplication for fractional anisotropy (left) and axial diffusivity (right). The threshold where an effect size is considered to be large [0.8, according to Cohen’s criteria <xref ref-type="bibr" rid="bib43">(43)</xref>] is represented by the vertical red dashed line. Black, green, and red dots represent small, medium, and large effect sizes, respectively. BCC, body of corpus callosum; CI, confidence interval; GCC, genu of the corpus callosum; LACR, left anterior corona radiata; LALIC, left anterior limb of the internal capsule; LC(CG), left cingulum (cingulate gyrus); LCP, left cerebral peduncle; LILF, left inferior longitudinal fasciculus; LPCR, left posterior corona radiata; LPLIC, left posterior limb of the internal capsule; LPTR, left posterior thalamic radiation; LRLIC, left retrolenticular part of internal capsule; LSCR, left superior corona radiata; LSLF, left superior longitudinal fasciculus; LUF, left uncinate fasciculus; RACR, right anterior corona radiata; RALIC, right anterior limb of the internal capsule; RC(CG), right cingulum (cingulate gyrus); RCP, right cerebral peduncle; RILF, right inferior longitudinal fasciculus; RPCR, right posterior corona radiata; RPLIC, right posterior limb of the internal capsule; RPTR, right posterior thalamic radiation; RRLIC, right retrolenticular part of internal capsule; RSCR, right superior corona radiata; RSLF, right superior longitudinal fasciculus; RUF, right uncinate fasciculus; SCC, splenium of the corpus callosum.</p></caption><graphic xlink:href="gr3"></graphic></fig><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><p>Comparisons Between the Deletion and Duplication of the 15q11.2 BP1-BP2 Region on FA, AD, RD, and MD</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Dependent Variable</th><th>ROI</th><th><italic>t</italic></th><th><italic>p</italic> Value (FDR Corrected)</th><th>Effect Size</th></tr></thead><tbody><tr><td rowspan="7">FA Del vs. Dup</td><td>LILF</td><td align="char">−3.15</td><td align="char">.02<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">0.86</td></tr><tr><td>LPCR</td><td align="char">−2.85</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">0.73</td></tr><tr><td>RPTR</td><td align="char">−2.68</td><td align="char">.04<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">0.65</td></tr><tr><td>LC(CG)</td><td align="char">−2.93</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">0.75</td></tr><tr><td>LALIC</td><td align="char">−2.97</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">0.76</td></tr><tr><td>RPLIC</td><td align="char">−4.31</td><td align="char">.003<xref ref-type="table-fn" rid="tbl3fnb">b</xref></td><td align="char">1.11</td></tr><tr><td>LPLIC</td><td align="char">−5.06</td><td align="char">.0006<xref ref-type="table-fn" rid="tbl3fnc">c</xref></td><td align="char">1.31</td></tr><tr><td rowspan="3">AD Del vs. Dup</td><td>BCC</td><td align="char">3.55</td><td align="char">.02<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.86</td></tr><tr><td>SCC</td><td align="char">−2.62</td><td align="char">.04<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.62</td></tr><tr><td>LPLIC</td><td align="char">−2.88</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">0.75</td></tr><tr><td rowspan="11">RD Del vs. Dup</td><td>BCC</td><td align="char">2.89</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.65</td></tr><tr><td>SCC</td><td align="char">2.88</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.68</td></tr><tr><td>RSLF</td><td align="char">2.69</td><td align="char">.04<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.70</td></tr><tr><td>LSLF</td><td align="char">2.69</td><td align="char">.04<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.69</td></tr><tr><td>RACR</td><td align="char">3.01</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.73</td></tr><tr><td>RSCR</td><td align="char">2.78</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.71</td></tr><tr><td>RPCR</td><td align="char">2.78</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.69</td></tr><tr><td>LC(CG)</td><td align="char">3.22</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.83</td></tr><tr><td>LALIC</td><td align="char">2.80</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.72</td></tr><tr><td>RPLIC</td><td align="char">3.32</td><td align="char">.02<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.84</td></tr><tr><td>LPLIC</td><td align="char">4.48</td><td align="char">.002<xref ref-type="table-fn" rid="tbl3fnb">b</xref></td><td align="char">−1.16</td></tr><tr><td rowspan="9">MD Del vs. Dup</td><td>BCC</td><td align="char">3.38</td><td align="char">.02<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.77</td></tr><tr><td>SCC</td><td align="char">3.31</td><td align="char">.02<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.78</td></tr><tr><td>RSLF</td><td align="char">2.99</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.78</td></tr><tr><td>LSLF</td><td align="char">2.95</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.77</td></tr><tr><td>RACR</td><td align="char">3.03</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.76</td></tr><tr><td>RSCR</td><td align="char">2.89</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.75</td></tr><tr><td>LSCR</td><td align="char">2.60</td><td align="char">.04<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.65</td></tr><tr><td>RPCR</td><td align="char">2.63</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.66</td></tr><tr><td>RC(CG)</td><td align="char">2.97</td><td align="char">.03<xref ref-type="table-fn" rid="tbl3fna">a</xref></td><td align="char">−0.67</td></tr></tbody></table><table-wrap-foot><fn><p>AD, axial diffusivity; BCC, body of corpus callosum; Del, deletion; Dup, duplication; FA, fractional anisotropy; FDR, false discovery rate; LALIC, left anterior limb of the internal capsule; LC(CG), left cingulum (cingulate gyrus portion); LILF, left inferior longitudinal fasciculus; LPCR, left posterior corona radiata; LPLIC, left posterior limb of the internal capsule; LSCR, left superior corona radiata; LSLF, left superior longitudinal fasciculus; MD, mean diffusivity; RACR, right anterior corona radiata; RC(CG), right cingulum (cingulate gyrus portion); RD, radial diffusivity; ROI, region of interest; RPCR, right posterior corona radiata; RPLIC, right posterior limb of the internal capsule; RPTR, right posterior thalamic radiation; RSCR, right superior corona radiata; RSLF, right superior longitudinal fasciculus; SCC, splenium of the corpus callosum.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fna"><label>a</label><p id="ntpara0020"><italic>p</italic> &lt; .05.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fnb"><label>b</label><p id="ntpara0025"><italic>p</italic> &lt; .01.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fnc"><label>c</label><p id="ntpara0030"><italic>p</italic> &lt; .001.</p></fn></table-wrap-foot></table-wrap></p>
</sec>
<sec id="sec2.3">
<title>Sex Differences</title>
<p id="p0100">A sex-by-dosage interaction model was used to investigate sex differences in relation to 15q11.2 BP1-BP2 dosage. Although we found no significant interaction effect in the whole-group analysis, we found significant differences in effect size when analyzing men and women separately, as assessed by using a two-tailed unpaired <italic>t</italic> test. Men showed larger effect size for increased FA (<italic>t =</italic> 2.56, <italic>p =</italic> .013) compared with women, and an overall large effect size in the whole brain (Cohen’s <italic>d</italic> = 0.99), whereas women showed a small effect size (Cohen’s <italic>d</italic> = 0.47). Moreover, men showed large effect sizes in more regions, namely in the genu and body of the corpus callosum, left ILF, anterior and posterior corona radiata, posterior thalamic radiation, cerebral peduncle, anterior limb of the IC, and PLIC. Women, however, showed a large effect size for increased FA in the left cingulum (cingulate gyrus portion) that is not seen in men (<xref ref-type="sec" rid="appsec1">Supplemental Figure S2</xref>).</p>
</sec>
</sec>
<sec id="sec3">
<title>Discussion</title>
<p id="p0105">In a whole-brain exploratory analysis, we found consistently increased FA and decreased RD and MD in individuals with the 15q11.2 BP1-BP2 deletion compared with individuals in the reciprocal duplication group. The duplication group showed significantly increased AD relative to the NoCNV and deletion groups (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Additional regional analyses (<xref ref-type="fig" rid="fig2">Figure 2</xref>) indicated that, in most WM tracts, the NoCNV group was intermediate between the deletion and duplication groups, suggesting a “mirror phenotype” <xref ref-type="bibr" rid="bib12">(12)</xref>. However, the deletion showed a greater impact on WM microstructure by showing larger effect sizes than in the duplication group (<xref ref-type="sec" rid="appsec1">Supplemental Table S1</xref>).</p>
<p id="p0110">We found the greatest effects in FA and RD bilaterally in the PLIC (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="sec" rid="appsec1">Supplemental Figure S1</xref>). The PLIC carries sensory information from the thalamus to the cortex, a key sensorimotor relay area implicated in schizophrenia <xref ref-type="bibr" rid="bib44">(44)</xref> and ASD <xref ref-type="bibr" rid="bib45">(45)</xref>. In schizophrenia, reductions in FA have been reported in the IC <xref ref-type="bibr" rid="bib4">(4)</xref>. However, in ASD patients, functional connectivity between motor regions of the thalamus and cortex was found to be hyperconnected <xref ref-type="bibr" rid="bib46">(46)</xref>, and a longitudinal study showed that the thalamus and IC undergo an atypical development trajectory in ASD, in which increasing connectivity from childhood through adolescence and adulthood was seen <xref ref-type="bibr" rid="bib47">(47)</xref>. The increased FA in the PLIC seen in the deletion group could be a result of an abnormal thalamus and IC development, which could relate to motor delays frequently reported in the BP1-BP2 deletion. Thus, a younger group is needed to look at the age trajectory of FA and its correlates with motor function outcome. We also found a large effect size in FA in the left ILF, a major WM tract thought to be critical to semantic processing and involved in dyslexia. Dyslexia and dyscalculia are common features in 15q11.2 BP1-BP2 deletion, and individuals with the deletion were previously shown to have a smaller fusiform gyrus <xref ref-type="bibr" rid="bib13">(13)</xref>, a structure that was shown to play a role in reading and mathematics and that connects to the ILF <xref ref-type="bibr" rid="bib48">(48)</xref>.</p>
<p id="p0115">Although all DTI changes seem to be consistent throughout the brain, regional analysis shows increases and decreases in AD in different WM tracts in the deletion (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref>). Previously, AD has been related to axonal damage and RD with axonal density and myelin <xref ref-type="bibr" rid="bib49">(49)</xref>. FA reflects the relative contribution of AD and RD. Because we find global increased FA, including areas where AD is decreased, the RD contribution seems to be stronger. The global decreased RD in the corpus callosum (and other areas) found here could be a result of increased axonal density that may also explain the increased WM volume found previously in the corpus callosum in healthy individuals with the deletion <xref ref-type="bibr" rid="bib12">12</xref>, <xref ref-type="bibr" rid="bib13">13</xref>. Furthermore, areas with reduced AD could be a result of reduced axonal integrity.</p>
<p id="p0120">Increased FA arising from abnormal WM organization has been reported before in patients with Williams syndrome, a chromosomal disorder associated with visuospatial deficits, in which higher FA in the superior longitudinal fasciculus tract was correlated with deficits in visuospatial construction <xref ref-type="bibr" rid="bib50">(50)</xref>. The globally increased FA in the deletion group could point to either a compensatory mechanism in response to primary deficits, as a protection against disease onset, or a diffuse dysregulation of neuronal dynamics, increasing the risk for psychiatric disorder. Hence, a central question is how each gene within this CNV region could contribute to this phenotype. All four genes in this region are highly conserved and expressed in human central nervous system, and may play a role in 15q11.2 BP1-BP2–associated phenotypes. Moreover, mutations in each gene were associated with different disorders: <italic>NIPA1</italic> with autosomal-dominant hereditary spastic paraplegia <xref ref-type="bibr" rid="bib17">(17)</xref>, <italic>NIPA2</italic> with childhood absence epilepsy <xref ref-type="bibr" rid="bib19">(19)</xref>, <italic>TUBGCP5</italic> with ADHD and obsessive-compulsive disorder <xref ref-type="bibr" rid="bib20">(20)</xref>, and <italic>CYFIP1</italic> with increasing susceptibility to ASD <xref ref-type="bibr" rid="bib51">(51)</xref> and with schizophrenia <xref ref-type="bibr" rid="bib52">(52)</xref>. Furthermore, dysregulations in mechanisms related to <italic>NIPA1</italic> and <italic>CYFIP1</italic> genes might have an impact on WM microstructure. <italic>NIPA1</italic> was found to inhibit the BMP signaling via interaction with BMP receptor type II <xref ref-type="bibr" rid="bib18">(18)</xref>, which is crucial for typical axonal growth, guidance, and differentiation. In a <italic>Drosophila</italic> model, enhanced BMP signaling resulted in abnormal distal axonal overgrowth at the presynaptic neuromuscular junction <xref ref-type="bibr" rid="bib53">(53)</xref>, which could result in increased axonal density. <italic>CYFIP1</italic>, on the other hand, has a crucial role in actin remodeling during neural wiring, in which dysregulations could result in changes in axonal density, organization, and myelination <xref ref-type="bibr" rid="bib54">54</xref>, <xref ref-type="bibr" rid="bib55">55</xref>.</p>
<p id="p0125">Recently, two articles by the same group [Green <italic>et al.</italic>
<xref ref-type="bibr" rid="bib27">(27)</xref> and Hall <italic>et al.</italic>
<xref ref-type="bibr" rid="bib28">(28)</xref>] reported increased FA and decreased RD and MD in FXS patients compared with IQ-matched control subjects. There is, therefore, a marked degree of overlap between our current findings in 15q11.2 BP1-BP2 deletion and WM changes in FXS, consistent a priori with the suggested molecular link between CYFIP1 and FMRP. The question arises, what common neural mechanism(s) may contribute to this overlap in WM phenotype? Here, evidence that both FMRP and CYFIP1 influence diverse aspects of synaptic function, as well as effects on dendritic architecture, may be of relevance <xref ref-type="bibr" rid="bib56">56</xref>, <xref ref-type="bibr" rid="bib57">57</xref>, <xref ref-type="bibr" rid="bib58">58</xref>. Both <italic>Fmr1</italic> knockout and <italic>Cyfip1</italic> hemizygous-null adult mice have in common an increased ratio of immature-to-mature spines <xref ref-type="bibr" rid="bib59">59</xref>, <xref ref-type="bibr" rid="bib60">60</xref>, <xref ref-type="bibr" rid="bib61">61</xref>, <xref ref-type="bibr" rid="bib62">62</xref>, <xref ref-type="bibr" rid="bib63">63</xref>. While the relationship between neuronal density and number of synapses per neuron is still not well understood, the observed increased FA in FXS <xref ref-type="bibr" rid="bib26">26</xref>, <xref ref-type="bibr" rid="bib27">27</xref> and 15q11.2 BP1-BP2 deletion (this study) could be caused by an increased neuronal density as an adaptive response to an increased number of immature spines and reduced functional synapses.</p>
<p id="p0130">Further speculations as to cellular/molecular mechanisms underlying the observed WM changes should, at this stage, be made with caution. DTI data are difficult to relate in a definitive way to underlying cellular changes, and their investigation would require postmortem or biopsy. To overcome this, translational models of human disease in animals are an attractive alternative to explore individual genotype-phenotype relationships <xref ref-type="bibr" rid="bib64">(64)</xref>. Therefore, owing to the potential role of <italic>CYFIP1</italic> in WM microstructure phenotypes associated with the 15q11.2 BP1-BP2 region, it would be informative to assess DTI data using low-dosage <italic>Cyfip1</italic> animal models. Furthermore, direct access to brain tissue would allow an analysis of underlying cellular changes relevant to the DTI findings.</p>
<p id="p0135">Clinical phenotypes of reciprocal CNVs have been broadly classified into four general categories: mirrored, identical, overlapping, and unique <xref ref-type="bibr" rid="bib65">(65)</xref>. The 16p11.2 <xref ref-type="bibr" rid="bib66">(66)</xref>, 1q21.1 <xref ref-type="bibr" rid="bib67">(67)</xref>, 3q29 <xref ref-type="bibr" rid="bib68">(68)</xref>, and 17p11.2 <xref ref-type="bibr" rid="bib69">(69)</xref> CNVs have been associated with mirrored phenotypes. Comparable to what we have reported here, increased FA was found in individuals with the 16p11.2 deletion, and opposite changes were found in individuals with the reciprocal duplication <xref ref-type="bibr" rid="bib70">(70)</xref>. The extensive reciprocal effects on WM reported here, and in previous studies <xref ref-type="bibr" rid="bib12">12</xref>, <xref ref-type="bibr" rid="bib13">13</xref>, show that the 15q11.2 BP1-BP2 also affects WM microstructure in a dosage-dependent way. When it comes to neuropsychiatric and behavioral findings at this locus, the picture is less clear <xref ref-type="bibr" rid="bib6">(6)</xref>. The microdeletion has been associated with developmental delay, schizophrenia, and autism, whereas duplication is generally not considered as a risk locus for schizophrenia <xref ref-type="bibr" rid="bib71">(71)</xref> and has not come out as a significant risk variant for developmental delay in recent large-scale genetic studies <xref ref-type="bibr" rid="bib72">(72)</xref>. Moreover, the microdeletion has been shown to have a greater impact on cognitive function in healthy individuals, particularly in the acquisition of mathematical skills and reading, whereas individuals in the duplication group performed similarly to the NoCNV group <xref ref-type="bibr" rid="bib12">12</xref>, <xref ref-type="bibr" rid="bib13">13</xref>. In this study, the microdeletion also shows a greater impact on WM microstructure, with larger effect sizes than the microduplication (<xref ref-type="sec" rid="appsec1">Supplemental Table S1</xref>), but the lack of cognitive data in this sample did not allow us to find correlations between increased FA and cognition.</p>
<p id="p0140">A limitation of this study was the impossibility to correct regions with crossing fibers, and reductions in the number of fibers in these regions might give rise to increased FA. The fact that we see an overall increased FA, and not only in crossing fiber regions, makes this less likely to be the main cause of the group differences. In the current analysis, we could not find a sex-by-dosage interaction, but men showed larger effect sizes than women (<xref ref-type="sec" rid="appsec1">Supplemental Figure S2</xref>), suggesting sex-dependent changes in WM. Although the molecular causality behind this sex difference is still unclear, sex bias has been observed in neurodevelopmental disorders <xref ref-type="bibr" rid="bib73">(73)</xref>. Moreover, 15q11.2 BP1-BP2 was shown to have a greater impact on ASD-related phenotype in men than women <xref ref-type="bibr" rid="bib8">(8)</xref>. Further larger studies will, however, be required to determine the exact interaction of sex and 15q11.2 BP1-BP2 dosage.</p>
<p id="p0145">Using complementary methods of analysis, this study shows a consistent pattern of WM microstructure alterations, which are consistent with recent FXS DTI studies, beginning to reveal brain mechanisms underlying the complex routes to psychopathology mediated by mutations at the 15q11.2 BP1-BP2 cytogenetic region. The reciprocal effects on WM microstructure, described here, suggest that deviations from normal gene dosage in each direction can lead to abnormalities in brain development, underlining the importance of studying how reciprocal chromosomal imbalances impact neural processes, which might have important implications for therapeutic intervention.</p>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<label>1</label>
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirov</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>CNVs in neuropsychiatric disorders</article-title>
<source/>Hum Mol Genet
          <volume>24</volume>
<year>2015</year>
<fpage>R45</fpage>
<lpage>R49</lpage>
<pub-id pub-id-type="pmid">26130694</pub-id>
</element-citation>
</ref>
<ref id="bib2">
<label>2</label>
<element-citation id="sref2" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grayton</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Collier</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Copy number variations in neurodevelopmental disorders</article-title>
<source/>Prog Neurobiol
          <volume>99</volume>
<year>2012</year>
<fpage>81</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">22813947</pub-id>
</element-citation>
</ref>
<ref id="bib3">
<label>3</label>
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Heuvel</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Fornito</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Brain networks in schizophrenia</article-title>
<source/>Neuropsychol Rev
          <volume>24</volume>
<year>2014</year>
<fpage>32</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">24500505</pub-id>
</element-citation>
</ref>
<ref id="bib4">
<label>4</label>
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McIntosh</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Job</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Moorhead</surname>
<given-names>T.W.J.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Lawrie</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Johnstone</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>White matter density in patients with schizophrenia, bipolar disorder and their unaffected relatives</article-title>
<source/>Biol Psychiatry
          <volume>58</volume>
<year>2005</year>
<fpage>254</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="pmid">15939409</pub-id>
</element-citation>
</ref>
<ref id="bib5">
<label>5</label>
<element-citation id="sref5" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>The 15q11.2 BP1–BP2 microdeletion syndrome: A review</article-title>
<source/>Int J Mol Sci
          <volume>16</volume>
<year>2015</year>
<fpage>4068</fpage>
<lpage>4082</lpage>
<pub-id pub-id-type="pmid">25689425</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<label>6</label>
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butler</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Clinical and genetic aspects of the 15q11.2 BP1–BP2 microdeletion disorder</article-title>
<source/>J Intellect Disabil Res
          <volume>61</volume>
<year>2017</year>
<fpage>568</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="pmid">28387067</pub-id>
</element-citation>
</ref>
<ref id="bib7">
<label>7</label>
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Kovel</surname>
<given-names>C.G.F.</given-names>
</name>
<name>
<surname>Trucks</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Helbig</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mefford</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Leu</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies</article-title>
<source/>Brain J Neurol
          <volume>133</volume>
<year>2010</year>
<fpage>23</fpage>
<lpage>32</lpage>
</element-citation>
</ref>
<ref id="bib8">
<label>8</label>
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaste</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Mohan</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Murtha</surname>
<given-names>M.T.</given-names>
</name>
</person-group>
<article-title>Modest impact on risk for autism spectrum disorder of rare copy number variants at 15q11.2, specifically breakpoints 1 to 2: Effects 15q11.2 CNV on autism risk</article-title>
<source/>Autism Res
          <volume>7</volume>
<year>2014</year>
<fpage>355</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="pmid">24821083</pub-id>
</element-citation>
</ref>
<ref id="bib9">
<label>9</label>
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefansson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cichon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pietiläinen</surname>
<given-names>O.P.H.</given-names>
</name>
<name>
<surname>Ingason</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Large recurrent microdeletions associated with schizophrenia</article-title>
<source/>Nature
          <volume>455</volume>
<year>2008</year>
<fpage>232</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="pmid">18668039</pub-id>
</element-citation>
</ref>
<ref id="bib10">
<label>10</label>
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Wassman</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Baxter</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Hensel</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders using an ultra-high resolution chromosomal microarray optimized for neurodevelopmental disorders</article-title>
<source/>Int J Mol Sci
          <volume>17</volume>
<year>2016</year>
<fpage>2070</fpage>
</element-citation>
</ref>
<ref id="bib11">
<label>11</label>
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burnside</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Pasion</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mikhail</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>N.H.</given-names>
</name>
<name>
<surname>Youngs</surname>
<given-names>E.L.</given-names>
</name>
</person-group>
<article-title>Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: A susceptibility region for neurological dysfunction including developmental and language delay</article-title>
<source/>Hum Genet
          <volume>130</volume>
<year>2011</year>
<fpage>517</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="pmid">21359847</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<label>12</label>
<element-citation id="sref12" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefansson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Meyer-Lindenberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Magnusdottir</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Morgen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Arnarsdottir</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>CNVs conferring risk of autism or schizophrenia affect cognition in controls</article-title>
<source/>Nature
          <volume>505</volume>
<year>2013</year>
<fpage>361</fpage>
<lpage>366</lpage>
<pub-id pub-id-type="pmid">24352232</pub-id>
</element-citation>
</ref>
<ref id="bib13">
<label>13</label>
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulfarsson</surname>
<given-names>M.O.</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>O.M.</given-names>
</name>
</person-group>
<article-title>15q11.2 CNV affects cognitive, structural and functional correlates of dyslexia and dyscalculia</article-title>
<source/>Transl Psychiatry
          <volume>7</volume>
<year>2017</year>
<fpage>e1109</fpage>
<pub-id pub-id-type="pmid">28440815</pub-id>
</element-citation>
</ref>
<ref id="bib14">
<label>14</label>
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butler</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Bittel</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Kibiryeva</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Talebizadeh</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy</article-title>
<source/>Pediatrics
          <volume>113</volume>
<year>2004</year>
<fpage>565</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="pmid">14993551</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<label>15</label>
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bittel</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Kibiryeva</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome</article-title>
<source/>Pediatrics
          <volume>118</volume>
<year>2006</year>
<fpage>e1276</fpage>
<lpage>e1283</lpage>
<pub-id pub-id-type="pmid">16982806</pub-id>
</element-citation>
</ref>
<ref id="bib16">
<label>16</label>
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chai</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Locke</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Greally</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Knoll</surname>
<given-names>J.H.M.</given-names>
</name>
<name>
<surname>Ohta</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dunai</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons</article-title>
<source/>Am J Hum Genet
          <volume>73</volume>
<year>2003</year>
<fpage>898</fpage>
<lpage>925</lpage>
<pub-id pub-id-type="pmid">14508708</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<label>17</label>
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rainier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Tokarz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Fink</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6)</article-title>
<source/>Am J Hum Genet
          <volume>73</volume>
<year>2003</year>
<fpage>967</fpage>
<lpage>971</lpage>
<pub-id pub-id-type="pmid">14508710</pub-id>
</element-citation>
</ref>
<ref id="bib18">
<label>18</label>
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsang</surname>
<given-names>H.T.H.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Connell</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Durrington</surname>
<given-names>H.J.</given-names>
</name>
</person-group>
<article-title>The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling</article-title>
<source/>Hum Mol Genet
          <volume>18</volume>
<year>2009</year>
<fpage>3805</fpage>
<lpage>3821</lpage>
<pub-id pub-id-type="pmid">19620182</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<label>19</label>
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Functional study of NIPA2 mutations identified from the patients with childhood absence epilepsy</article-title>
<source/>PloS One
          <volume>9</volume>
<year>2014</year>
<fpage>e109749</fpage>
<pub-id pub-id-type="pmid">25347071</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<label>20</label>
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grabli</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McCairn</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Agid</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Féger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>François</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study</article-title>
<source/>Brain J Neurol
          <volume>127</volume>
<year>2004</year>
<fpage>2039</fpage>
<lpage>2054</lpage>
</element-citation>
</ref>
<ref id="bib21">
<label>21</label>
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname>
<given-names>K.-J.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Ursini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>N.-S.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity</article-title>
<source/>Cell Stem Cell
          <volume>15</volume>
<year>2014</year>
<fpage>79</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">24996170</pub-id>
</element-citation>
</ref>
<ref id="bib22">
<label>22</label>
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Borek</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Padrick</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Metlagel</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Structure and control of the actin regulatory WAVE complex</article-title>
<source/>Nature
          <volume>468</volume>
<year>2010</year>
<fpage>533</fpage>
<lpage>538</lpage>
<pub-id pub-id-type="pmid">21107423</pub-id>
</element-citation>
</ref>
<ref id="bib23">
<label>23</label>
<element-citation id="sref23" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pasciuto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Di Marino</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Buzzi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation</article-title>
<source/>Neuron
          <volume>79</volume>
<year>2013</year>
<fpage>1169</fpage>
<lpage>1182</lpage>
<pub-id pub-id-type="pmid">24050404</pub-id>
</element-citation>
</ref>
<ref id="bib24">
<label>24</label>
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Napoli</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mercaldo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Boyl</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Eleuteri</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zalfa</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>De Rubeis</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a New 4E-BP</article-title>
<source/>Cell
          <volume>134</volume>
<year>2008</year>
<fpage>1042</fpage>
<lpage>1054</lpage>
<pub-id pub-id-type="pmid">18805096</pub-id>
</element-citation>
</ref>
<ref id="bib25">
<label>25</label>
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnea-Goraly</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Eliez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hedeus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Moseley</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>White matter tract alterations in fragile X syndrome: Preliminary evidence from diffusion tensor imaging</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <volume>118</volume>
<year>2003</year>
<fpage>81</fpage>
<lpage>88</lpage>
</element-citation>
</ref>
<ref id="bib26">
<label>26</label>
<element-citation id="sref26" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lozano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rosero</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Hagerman</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Fragile X spectrum disorders</article-title>
<source/>Intractable Rare Dis Res
          <volume>3</volume>
<year>2014</year>
<fpage>134</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="pmid">25606363</pub-id>
</element-citation>
</ref>
<ref id="bib27">
<label>27</label>
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Barnea-Goraly</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Raman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Lightbody</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Specific effect of the fragile-X mental retardation-1 gene (FMR1) on white matter microstructure</article-title>
<source/>Br J Psychiatry
          <volume>207</volume>
<year>2015</year>
<fpage>143</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="pmid">25792692</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<label>28</label>
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Dougherty</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Profiles of aberrant white matter microstructure in fragile X syndrome</article-title>
<source/>Neuroimage Clin
          <volume>11</volume>
<year>2016</year>
<fpage>133</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="pmid">26937381</pub-id>
</element-citation>
</ref>
<ref id="bib29">
<label>29</label>
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheehan</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Lecrubier</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sheehan</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Amorim</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Janavs</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weiller</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>
<source/>J Clin Psychiatry
          <volume>59</volume>
<issue>suppl 20</issue>
<year>1998</year>
<fpage>22</fpage>
<lpage>33</lpage>
<comment>quiz 34–57</comment>
</element-citation>
</ref>
<ref id="bib30">
<label>30</label>
<element-citation id="sref30" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Woerner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Overstreet</surname>
<given-names>K.</given-names>
</name>
</person-group>
<chapter-title>Wechsler Abbreviated Scale of Intelligence (WASI)</chapter-title>
<year>1999</year>
<publisher-name>Psychological Corporation</publisher-name>
<publisher-loc>San Antonio, TX</publisher-loc>
</element-citation>
</ref>
<ref id="bib31">
<label>31</label>
<element-citation id="sref31" publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Guðmundsson</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Staðlað greindarpróf fyrir fullorðna á Íslandi: WASIIS. (Standardized intelligence test for adults in Iceland: WASIIS.)</article-title>
<comment>Available at:</comment>
<ext-link ext-link-type="uri" id="intref0020" xlink:href="https://www.hirsla.lsh.is/handle/2336/620069">https://www.hirsla.lsh.is/handle/2336/620069</ext-link>
<year>2016</year>
<comment>Accessed September 20, 2018</comment>
</element-citation>
</ref>
<ref id="bib32">
<label>32</label>
<element-citation id="sref32" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Leemans</surname>
<given-names>A.</given-names>
</name>
</person-group>
<chapter-title>Diffusion tensor imaging</chapter-title>
<person-group person-group-type="editor">
<name>
<surname>Modo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bulte</surname>
<given-names>J.W.M.</given-names>
</name>
</person-group>
<source/>Magnetic Resonance Neuroimaging: Methods and Protocols
          <year>2011</year>
<publisher-name>Humana Press</publisher-name>
<publisher-loc>Totowa, NJ</publisher-loc>
<fpage>127</fpage>
<lpage>144</lpage>
</element-citation>
</ref>
<ref id="bib33">
<label>33</label>
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soares</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Marques</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>A hitchhiker’s guide to diffusion tensor imaging</article-title>
<source/>Front Neurosci
          <volume>7</volume>
<year>2013</year>
<fpage>31</fpage>
<pub-id pub-id-type="pmid">23486659</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<label>34</label>
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leemans</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jeurissen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sijbers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D.K.</given-names>
</name>
</person-group>
<article-title>ExploreDTI: A graphical toolbox for processing, analyzing, and visualizing diffusion MR data</article-title>
<source/>Proc Intl Soc Mag Reson Med
          <volume>17</volume>
<year>2009</year>
<fpage>3537</fpage>
</element-citation>
</ref>
<ref id="bib35">
<label>35</label>
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Fast robust automated brain extraction</article-title>
<source/>Hum Brain Mapp
          <volume>17</volume>
<year>2002</year>
<fpage>143</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="pmid">12391568</pub-id>
</element-citation>
</ref>
<ref id="bib36">
<label>36</label>
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leemans</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D.K.</given-names>
</name>
</person-group>
<article-title>The B-matrix must be rotated when correcting for subject motion in DTI data</article-title>
<source/>Magn Reson Med
          <volume>61</volume>
<year>2009</year>
<fpage>1336</fpage>
<lpage>1349</lpage>
<pub-id pub-id-type="pmid">19319973</pub-id>
</element-citation>
</ref>
<ref id="bib37">
<label>37</label>
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lemaitre</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Barnett</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Marenco</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Comparison of EPI distortion correction methods in diffusion tensor MRI using a novel framework</article-title>
<source/>Med Image Comput Comput Assist Interv
          <volume>11</volume>
<year>2008</year>
<fpage>321</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="pmid">18982621</pub-id>
</element-citation>
</ref>
<ref id="bib38">
<label>38</label>
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Staring</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Viergever</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Pluim</surname>
<given-names>J.P.W.</given-names>
</name>
</person-group>
<article-title>elastix: A toolbox for intensity-based medical image registration</article-title>
<source/>IEEE Trans Med Imaging
          <volume>29</volume>
<year>2010</year>
<fpage>196</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="pmid">19923044</pub-id>
</element-citation>
</ref>
<ref id="bib39">
<label>39</label>
<element-citation id="sref39" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Johansen-Berg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rueckert</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>C.E.</given-names>
</name>
</person-group>
<article-title>Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data</article-title>
<source/>Neuroimage
          <volume>31</volume>
<year>2006</year>
<fpage>1487</fpage>
<lpage>1505</lpage>
<pub-id pub-id-type="pmid">16624579</pub-id>
</element-citation>
</ref>
<ref id="bib40">
<label>40</label>
<element-citation id="sref40" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>T.E.</given-names>
</name>
</person-group>
<article-title>Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference</article-title>
<source/>Neuroimage
          <volume>44</volume>
<year>2009</year>
<fpage>83</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">18501637</pub-id>
</element-citation>
</ref>
<ref id="bib41">
<label>41</label>
<element-citation id="sref41" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wakana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>van Zijl</surname>
<given-names>P.C.M.</given-names>
</name>
<name>
<surname>Nagae-Poetscher</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<chapter-title>MRI Atlas of Human White Matter</chapter-title>
<edition>1st ed.</edition>
<year>2005</year>
<publisher-name>Elsevier</publisher-name>
<publisher-loc>New York</publisher-loc>
</element-citation>
</ref>
<ref id="bib42">
<label>42</label>
<element-citation id="sref42" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benjamini</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hochberg</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Controlling the false discovery rate: A practical and powerful approach to multiple testing</article-title>
<source/>J R Stat Soc Ser B Methodol
          <volume>57</volume>
<year>1995</year>
<fpage>289</fpage>
<lpage>300</lpage>
</element-citation>
</ref>
<ref id="bib43">
<label>43</label>
<element-citation id="sref43" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>J.</given-names>
</name>
</person-group>
<chapter-title>Chapter 1. The concepts of power analysis</chapter-title>
<source/>Statistical Power Analysis for the Behavioral Sciences (Revised Edition)
          <year>1977</year>
<publisher-name>Academic Press</publisher-name>
<publisher-loc>San Diego, CA</publisher-loc>
<fpage>1</fpage>
<lpage>17</lpage>
</element-citation>
</ref>
<ref id="bib44">
<label>44</label>
<element-citation id="sref44" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pergola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Selvaggi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Trizio</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bertolino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blasi</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The role of the thalamus in schizophrenia from a neuroimaging perspective</article-title>
<source/>Neurosci Biobehav Rev
          <volume>54</volume>
<year>2015</year>
<fpage>57</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">25616183</pub-id>
</element-citation>
</ref>
<ref id="bib45">
<label>45</label>
<element-citation id="sref45" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doll</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Broadie</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models</article-title>
<source/>Front Cell Neurosci
          <volume>8</volume>
<year>2014</year>
<fpage>30</fpage>
<pub-id pub-id-type="pmid">24570656</pub-id>
</element-citation>
</ref>
<ref id="bib46">
<label>46</label>
<element-citation id="sref46" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizuno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Villalobos</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Dahl</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>R.-A.</given-names>
</name>
</person-group>
<article-title>Partially enhanced thalamocortical functional connectivity in autism</article-title>
<source/>Brain Res
          <volume>1104</volume>
<year>2006</year>
<fpage>160</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="pmid">16828063</pub-id>
</element-citation>
</ref>
<ref id="bib47">
<label>47</label>
<element-citation id="sref47" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLaughlin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Travers</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Dadalko</surname>
<given-names>O.I.</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Tromp</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Adluru</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Longitudinal development of thalamic and internal capsule microstructure in autism spectrum disorder</article-title>
<source/>Autism Res
          <volume>11</volume>
<year>2018</year>
<fpage>450</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="pmid">29251836</pub-id>
</element-citation>
</ref>
<ref id="bib48">
<label>48</label>
<element-citation id="sref48" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiernan</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Anatomy of the temporal lobe</article-title>
<source/>Epilepsy Res Treat
          <volume>2012</volume>
<year>2012</year>
<fpage>176157</fpage>
<pub-id pub-id-type="pmid">22934160</pub-id>
</element-citation>
</ref>
<ref id="bib49">
<label>49</label>
<element-citation id="sref49" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Hecke</surname>
<given-names>W.V.</given-names>
</name>
<name>
<surname>Emsell</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sunaert</surname>
<given-names>S.</given-names>
</name>
</person-group>
<chapter-title>Diffusion Tensor Imaging: A Practical Handbook</chapter-title>
<year>2015</year>
<publisher-name>Springer</publisher-name>
<publisher-loc>New York</publisher-loc>
</element-citation>
</ref>
<ref id="bib50">
<label>50</label>
<element-citation id="sref50" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoeft</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Barnea-Goraly</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Golarai</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>More is not always better: Increased fractional anisotropy of superior longitudinal fasciculus associated with poor visuospatial abilities in Williams syndrome</article-title>
<source/>J Neurosci
          <volume>27</volume>
<year>2007</year>
<fpage>11960</fpage>
<lpage>11965</lpage>
<pub-id pub-id-type="pmid">17978036</pub-id>
</element-citation>
</ref>
<ref id="bib51">
<label>51</label>
<element-citation id="sref51" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toma</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Torrico</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hervás</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Valdés-Mas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tristán-Noguero</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Padillo</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations</article-title>
<source/>Mol Psychiatry
          <volume>19</volume>
<year>2014</year>
<fpage>784</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="pmid">23999528</pub-id>
</element-citation>
</ref>
<ref id="bib52">
<label>52</label>
<element-citation id="sref52" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tam</surname>
<given-names>G.W.C.</given-names>
</name>
<name>
<surname>van de Lagemaat</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Redon</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Strathdee</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Croning</surname>
<given-names>M.D.R.</given-names>
</name>
<name>
<surname>Malloy</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Confirmed rare copy number variants implicate novel genes in schizophrenia</article-title>
<source/>Biochem Soc Trans
          <volume>38</volume>
<year>2010</year>
<fpage>445</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="pmid">20298200</pub-id>
</element-citation>
</ref>
<ref id="bib53">
<label>53</label>
<element-citation id="sref53" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>W.R.</given-names>
</name>
<name>
<surname>Tsang</surname>
<given-names>H.T.H.</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>O’Kane</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules</article-title>
<source/>Nat Neurosci
          <volume>10</volume>
<year>2007</year>
<fpage>177</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="pmid">17220882</pub-id>
</element-citation>
</ref>
<ref id="bib54">
<label>54</label>
<element-citation id="sref54" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dent</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Gertler</surname>
<given-names>F.B.</given-names>
</name>
</person-group>
<article-title>Cytoskeletal dynamics and transport in growth cone motility and axon guidance</article-title>
<source/>Neuron
          <volume>40</volume>
<year>2003</year>
<fpage>209</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">14556705</pub-id>
</element-citation>
</ref>
<ref id="bib55">
<label>55</label>
<element-citation id="sref55" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauer</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>Richter-Landsberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ffrench-Constant</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Role of the oligodendroglial cytoskeleton in differentiation and myelination</article-title>
<source/>Glia
          <volume>57</volume>
<year>2009</year>
<fpage>1691</fpage>
<lpage>1705</lpage>
<pub-id pub-id-type="pmid">19455583</pub-id>
</element-citation>
</ref>
<ref id="bib56">
<label>56</label>
<element-citation id="sref56" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sidorov</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Auerbach</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Fragile X mental retardation protein and synaptic plasticity</article-title>
<source/>Mol Brain
          <volume>6</volume>
<year>2013</year>
<fpage>15</fpage>
<pub-id pub-id-type="pmid">23566911</pub-id>
</element-citation>
</ref>
<ref id="bib57">
<label>57</label>
<element-citation id="sref57" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antar</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Bassell</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses</article-title>
<source/>Mol Cell Neurosci
          <volume>32</volume>
<year>2006</year>
<fpage>37</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">16631377</pub-id>
</element-citation>
</ref>
<ref id="bib58">
<label>58</label>
<element-citation id="sref58" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bassell</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Fragile X mental retardation protein is involved in protein synthesis-dependent collapse of growth cones induced by semaphorin-3A</article-title>
<source/>Front Neural Circuits
          <volume>3</volume>
<year>2009</year>
<fpage>11</fpage>
<pub-id pub-id-type="pmid">19826618</pub-id>
</element-citation>
</ref>
<ref id="bib59">
<label>59</label>
<element-citation id="sref59" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tessier</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Broadie</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning</article-title>
<source/>Development
          <volume>135</volume>
<year>2008</year>
<fpage>1547</fpage>
<lpage>1557</lpage>
<pub-id pub-id-type="pmid">18321984</pub-id>
</element-citation>
</ref>
<ref id="bib60">
<label>60</label>
<element-citation id="sref60" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nimchinsky</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Oberlander</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Svoboda</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Abnormal development of dendritic spines in FMR1 knock-out mice</article-title>
<source/>J Neurosci
          <volume>21</volume>
<year>2001</year>
<fpage>5139</fpage>
<lpage>5146</lpage>
<pub-id pub-id-type="pmid">11438589</pub-id>
</element-citation>
</ref>
<ref id="bib61">
<label>61</label>
<element-citation id="sref61" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pathania</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Davenport</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Muir</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sheehan</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>López-Doménech</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kittler</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines</article-title>
<source/>Transl Psychiatry
          <volume>4</volume>
<year>2014</year>
<fpage>e374</fpage>
<pub-id pub-id-type="pmid">24667445</pub-id>
</element-citation>
</ref>
<ref id="bib62">
<label>62</label>
<element-citation id="sref62" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oguro-Ando</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rosensweig</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Werling</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bill</surname>
<given-names>B.R.</given-names>
</name>
</person-group>
<article-title>Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR</article-title>
<source/>Mol Psychiatry
          <volume>20</volume>
<year>2015</year>
<fpage>1069</fpage>
<lpage>1078</lpage>
<pub-id pub-id-type="pmid">25311365</pub-id>
</element-citation>
</ref>
<ref id="bib63">
<label>63</label>
<element-citation id="sref63" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abekhoukh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Grossi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zongaro</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maurin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Madrigal</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes</article-title>
<source/>Dis Model Mech
          <volume>10</volume>
<year>2017</year>
<fpage>463</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="pmid">28183735</pub-id>
</element-citation>
</ref>
<ref id="bib64">
<label>64</label>
<element-citation id="sref64" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schofield</surname>
<given-names>P.N.</given-names>
</name>
<name>
<surname>Hoehndorf</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gkoutos</surname>
<given-names>G.V.</given-names>
</name>
</person-group>
<article-title>Mouse genetic and phenotypic resources for human genetics</article-title>
<source/>Hum Mutat
          <volume>33</volume>
<year>2012</year>
<fpage>826</fpage>
<lpage>836</lpage>
<pub-id pub-id-type="pmid">22422677</pub-id>
</element-citation>
</ref>
<ref id="bib65">
<label>65</label>
<element-citation id="sref65" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golzio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Katsanis</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Genetic architecture of reciprocal CNVs</article-title>
<source/>Curr Opin Genet Dev
          <volume>23</volume>
<year>2013</year>
<fpage>240</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="pmid">23747035</pub-id>
</element-citation>
</ref>
<ref id="bib66">
<label>66</label>
<element-citation id="sref66" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Korn</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Fossdal</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Association between microdeletion and microduplication at 16p11.2 and autism</article-title>
<source/>N Engl J Med
          <volume>358</volume>
<year>2008</year>
<fpage>667</fpage>
<lpage>675</lpage>
<pub-id pub-id-type="pmid">18184952</pub-id>
</element-citation>
</ref>
<ref id="bib67">
<label>67</label>
<element-citation id="sref67" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunetti-Pierri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Scaglia</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Belmont</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bacino</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Sahoo</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities</article-title>
<source/>Nat Genet
          <volume>40</volume>
<year>2008</year>
<fpage>1466</fpage>
<lpage>1471</lpage>
<pub-id pub-id-type="pmid">19029900</pub-id>
</element-citation>
</ref>
<ref id="bib68">
<label>68</label>
<element-citation id="sref68" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballif</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Theisen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Coppinger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gowans</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Hersh</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Madan-Khetarpal</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication</article-title>
<source/>Mol Cytogenet
          <volume>1</volume>
<year>2008</year>
<fpage>8</fpage>
<pub-id pub-id-type="pmid">18471269</pub-id>
</element-citation>
</ref>
<ref id="bib69">
<label>69</label>
<element-citation id="sref69" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacaria</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Potocki</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>A duplication CNV that conveys traits reciprocal to metabolic syndrome and protects against diet-induced obesity in mice and men</article-title>
<source/>PLoS Genet
          <volume>8</volume>
<year>2012</year>
<fpage>e1002713</fpage>
<pub-id pub-id-type="pmid">22654670</pub-id>
</element-citation>
</ref>
<ref id="bib70">
<label>70</label>
<element-citation id="sref70" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>Y.S.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Pojman</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Thieu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bukshpun</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wakahiro</surname>
<given-names>M.L.J.</given-names>
</name>
</person-group>
<article-title>Reciprocal white matter alterations due to 16p11.2 chromosomal deletions versus duplications: White matter microstructure in 16p11.2 CNVs</article-title>
<source/>Hum Brain Mapp
          <volume>37</volume>
<year>2016</year>
<fpage>2833</fpage>
<lpage>2848</lpage>
<pub-id pub-id-type="pmid">27219475</pub-id>
</element-citation>
</ref>
<ref id="bib71">
<label>71</label>
<element-citation id="sref71" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirov</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>J.T.R.</given-names>
</name>
<name>
<surname>Escott-Price</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Georgieva</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>The penetrance of copy number variations for schizophrenia and developmental delay</article-title>
<source/>Biol Psychiatry
          <volume>75</volume>
<year>2014</year>
<fpage>378</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="pmid">23992924</pub-id>
</element-citation>
</ref>
<ref id="bib72">
<label>72</label>
<element-citation id="sref72" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coe</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Witherspoon</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>van Bon</surname>
<given-names>B.W.M.</given-names>
</name>
<name>
<surname>Vulto-van Silfhout</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Bosco</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Refining analyses of copy number variation identifies specific genes associated with developmental delay</article-title>
<source/>Nat Genet
          <volume>46</volume>
<year>2014</year>
<fpage>1063</fpage>
<lpage>1071</lpage>
<pub-id pub-id-type="pmid">25217958</pub-id>
</element-citation>
</ref>
<ref id="bib73">
<label>73</label>
<element-citation id="sref73" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rinehart</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Cornish</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Tonge</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Gender differences in neurodevelopmental disorders: Autism and fragile x syndrome</article-title>
<source/>Curr Top Behav Neurosci
          <volume>8</volume>
<year>2011</year>
<fpage>209</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="pmid">21769728</pub-id>
</element-citation>
</ref>
</ref-list>
<sec id="appsec1" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p id="p0165">
<supplementary-material content-type="local-data" id="mmc1">
<caption>
<title>Supplemental Material</title>
</caption>
<media xlink:href="mmc1.pdf"></media>
</supplementary-material>
</p>
</sec>
<ack id="ack0010">
<title>Acknowledgments and Disclosures</title>
<p>This work was supported by <funding-source id="gs1">Innovative Medicines Initiative</funding-source> Joint Undertaking Grant Nos. 115008 (NEWMEDS [to KS]) and 115300 (EUAIMS [to KS]), of which resources were composed of European Federation of Pharmaceutical Industries and Associations in-kind contribution and financial contribution from <funding-source id="gs2">European Union Seventh Framework Programme</funding-source> (EU-FP7/2007-2013) Grant No. 602450 (IMAGEMEND) and FP7-People-2011-IAPP Grant No. 286213 (PsychDPC); <funding-source id="gs3">Wellcome Trust Strategic Award</funding-source> “DEFINE” Grant No. 100202/Z/12/Z (to JH); and core support from the <funding-source id="gs4">Neuroscience and Mental Health Research Institute</funding-source>, <funding-source id="gs5">Cardiff University</funding-source> (PhD grant to AS). Approval for this study was obtained from the National Bioethics Committee of Iceland and the Icelandic Data Protection Authority.</p>
<p>We are grateful to the participants and we thank the nurses and staff at the Research Recruitment Centre and technicians and staff at Röntgen Domus.</p>
<p>MOU, HS, OG, GBW, and KS are employees of deCODE genetics/Amgen. The remaining authors report no biomedical financial interests or potential conflicts of interest.</p>
</ack>
<fn-group>
<fn fn-type="supplementary-material" id="appsec2">
<p id="p0170">Supplementary material cited in this article is available online at <ext-link ext-link-type="uri" id="intref0015" xlink:href="https://doi.org/10.1016/j.biopsych.2018.11.004">https://doi.org/10.1016/j.biopsych.2018.11.004</ext-link>.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>